News

AstraZeneca PLC ( NASDAQ: AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET ...
Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.
New guidelines offer actionable recommendations for diagnosing and managing asthma, making it easier for primary care ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local doctors and hospitals.
AstraZeneca is currently conducting a clinical study titled A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Benralizumab on ...
Why Asthma Controller Medicines Aren’t Optional, But Essential Despite the recent claims of being overprescribed, only 35% of asthma patients use lifesaving controller meds, putting them at risk.
AstraZeneca suffers defeat over $7bn diabetes patentPharma giant can’t stop generics from unveiling copies of flagship product | Lord Justice Arnold upholds UK findings of lack of inventive step and ...
For adolescents, GINA recommends the use of low-dose ICS combined with formoterol (12). However, asthma medications in children may cause side effects, such as reduced growth velocity and adrenal ...
SIGNIFICANT EVENTS DURING 1 APRIL - 30 JUNE 2025In April, Iconovo announced an organizational change expected to reduce annual costs by approximately 14-16 MSEK starting in the third quarter of 2025.